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A G1-like state allows HIV-1 to bypass SAMHD1
restriction in macrophages
Petra Mlcochova1, Katherine A Sutherland1, Sarah A Watters1, Cosetta Bertoli2, Rob AM de Bruin2,
Jan Rehwinkel3, Stuart J Neil4, Gina M Lenzi5, Baek Kim5, Asim Khwaja6, Matthew C Gage7,
Christiana Georgiou7, Alexandra Chittka7, Simon Yona7, Mahdad Noursadeghi1, Greg J Towers1 &
Ravindra K Gupta1,8,*
Abstract
An unresolved question is how HIV-1 achieves efficient replication
in terminally differentiated macrophages despite the restriction
factor SAMHD1. We reveal inducible changes in expression of cell
cycle-associated proteins including MCM2 and cyclins A, E, D1/D3
in macrophages, without evidence for DNA synthesis or mitosis.
These changes are induced by activation of the Raf/MEK/ERK
kinase cascade, culminating in upregulation of CDK1 with subse-
quent SAMHD1 T592 phosphorylation and deactivation of its
antiviral activity. HIV infection is limited to these G1-like phase
macrophages at the single-cell level. Depletion of SAMHD1 in
macrophages decouples the association between infection and
expression of cell cycle-associated proteins, with terminally dif-
ferentiated macrophages becoming highly susceptible to HIV-1.
We observe both embryo-derived and monocyte-derived tissue-
resident macrophages in a G1-like phase at frequencies approach-
ing 20%, suggesting how macrophages sustain HIV-1 replication
in vivo. Finally, we reveal a SAMHD1-dependent antiretroviral
activity of histone deacetylase inhibitors acting via p53 activation.
These data provide a basis for host-directed therapeutic
approaches aimed at limiting HIV-1 burden in macrophages that
may contribute to curative interventions.
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Introduction
SAMHD1, a deoxynucleotide-triphosphate (dNTP) hydrolase,
restricts HIV-1 reverse transcription (RT) through decreasing levels
of dNTPs (Goldstone et al, 2011; Lahouassa et al, 2012; Schmidt
et al, 2015). SAMHD1 phosphorylation at position T592 mediated
by cyclin-dependent kinases CDK1/2 (Cribier et al, 2013; White
et al, 2013) in actively dividing cells impairs the dNTP hydrolase
activity and allows viral DNA synthesis to occur (Cribier et al, 2013;
Arnold et al, 2015). Some lentiviruses have evolved counter-
measures against SAMHD1; for example, the HIV-2/SIVsm lineage
encodes the Vpx protein that degrades SAMHD1 and allows infec-
tion of otherwise SAMHD1-positive target cells (Kaushik et al, 2009;
Hrecka et al, 2011; Laguette et al, 2011). How pandemic HIV-1
strains achieve efficient infection of terminally differentiated macro-
phages in vivo without a Vpx-like activity has remained a significant
unresolved question that has limited our understanding of HIV
tropism and pathogenesis (Watters et al, 2013).
Here, we reveal dynamic expression of cell cycle-associated
proteins in non-dividing macrophages that do not culminate in DNA
synthesis or mitosis. These changes are dependent on the canonical
mitogen/growth factor-activated Raf/MEK/ERK signalling pathway
and are sufficient to deactivate the potent HIV-1 restriction mediated
by SAMHD1. Moreover, we show in two distinct populations of
tissue-resident macrophages in mice that 20% of cells express a G1-
like activation profile, providing not only an explanation for the
ability of macrophages to sustain high levels of HIV-1 replication
but also offering a therapeutic target for limiting HIV-1 burden in
these vital innate immune cells.
1 Division of Infection and Immunity, University College London, London, UK
2 MRC Laboratory for Molecular Cell Biology, University College London, London, UK
3 Medical Research Council Human Immunology Unit, Radcliffe Department of Medicine, Medical Research Council Weatherall Institute of Molecular Medicine, University of
Oxford, Oxford, UK
4 Division of Immunology, Infection and Inflammatory Disease, King’s College, London, UK
5 Department of Pediatrics, Center for Drug Discovery, Emory School of Medicine, Atlanta, GA, USA
6 Research Department of Haematology, UCL, London, UK
7 Division of Medicine, University College London, London, UK
8 Africa Health Research Institute, KwaZulu Natal, South Africa
*Corresponding author. Tel: +44 20 7679 2000; E-mail: ravindra.gupta@ucl.ac.uk
The EMBO Journal Vol 36 | No 5 | 2017 ª 2017 The Authors. Published under the terms of the CC BY 4.0 license604
Published online: January 25, 2017 
Results
Terminally differentiated macrophages stimulated to enter a G1-
like phase are highly susceptible to HIV-1 infection
We observed that culture of human monocyte-derived macrophages
(MDM) in foetal calf serum/FCS (stimulated cells), as opposed to
human serum/HS (unstimulated cells), led to a significant increase
in permissivity to HIV-1 infection (Figs 1A–C and EV1A–E). As
expected, there was significant donor variation in absolute permis-
sivity to HIV (Fig EV1B). An increase in viral permissivity under
stimulating conditions was observed for single-round VSV-G-
pseudotyped HIV-1 virus (Figs 1A and EV1A and B) and full-length
infectious HIV-1 molecular clones (Figs 1B and C, and EV1C and D),
including macrophage tropic viruses (BaL, YU-2), clinical HIV-1
isolates (Fig EV1C and D) and HIV-1 with capsid mutations known
to alter interactions with cyclophilin and CPSF6 leading to altered
reverse transcription, retargeted integration and triggering of innate
sensing (Fig EV1E). The infection enhancement was observed post-
entry at the step of reverse transcription (Figs 1B and EV1F). The
effect of FCS on infection was lost when charcoal-stripped FCS was
used but not when boiled FCS or a human serum/foetal calf serum
mixture (1:1) was used, suggesting the existence of a heat stable
stimulatory factor in FCS rather than an inhibitory factor in HS
(Fig EV1A).
The differential effects of FCS and HS suggested an approach to
uncovering mechanisms regulating HIV-1 permissivity in macro-
phages. We compared the transcriptomes of MDM differentiated in
HS (unstimulated cells, UNSTIM) or FCS (stimulated cells, STIM)
aiming to discover signalling pathways that contribute to higher
HIV-1 permissivity. Comparison of transcriptional profiles for a
predefined gene signature that discriminates macrophages from
other cell types (Tomlinson et al, 2012) clearly shows that HS and
FCS cultured MDM cluster together and are distinct from closely
related myeloid cells (Fig 1D). Moreover, they express similar
macrophage markers (Fig EV2). However, use of ingenuity pathway
analysis to evaluate genes associated with high permissivity to HIV-1
infection revealed enrichment in a number of molecular/cellular
functions including cell cycle regulation, growth and proliferation,
and cell death or survival (Fig 1E). The top canonical pathway was
enriched for genes encoding proteins involved in cell cycle regula-
tion including cyclins (Figs 1F and EV3A, and Table EV1). These
observations were validated at the protein expression level (Fig 1G).
Stimulated cells showed an increase in D-type cyclins D1 and D3,
which accumulate as cells progress through G1 phase (Baldin et al,
1993; Sherr, 1993, 1996). Cyclin D2 was below detectable levels
under both conditions (Fig 1G). We also observed an increase in
cyclins A and E, E2F6 and Geminin—all known to accumulate
during cell cycle entry (Coverley et al, 2002; Bertoli et al, 2013;
Fragkos et al, 2015). Of note, CDK1—a key player in cell cycle
progression—was also upregulated in stimulated cells, along with
MCM2 (minichromosome maintenance complex component 2)
(Fig 1G and H), a replication origin licensing factor that is expressed
from G1 (but not in G0) (Baldin et al, 1993; Sherr, 1996; Su &
O’Farrell, 1997; Tsuruga et al, 1997; Musahl et al, 1998; Stoeber
et al, 1998, 2001; Williams et al, 1998). Importantly, p27 expression
was reduced following MDM stimulation (Fig 1G). p27 is a cyclin-
dependent kinase inhibitor which is highly expressed in quiescent
cells and which decreases after cell cycle re-entry (Sherr & Roberts,
1999).
We further compared stimulated and unstimulated cells at the
single-cell level for expression of cell cycle-associated proteins,
which are absent in G0/quiescent/terminally differentiated cells but
(i) are found at all cell cycle phases (MCM2) (Masai et al, 2010), (ii)
that accumulate in S and G2/M phases (Geminin) (Fragkos et al,
2015) and (iii) are specific to active DNA synthesis in cells and
therefore a marker of S phase (EdU incorporation) (Fig 1H). Single
cell-imaging analysis using an automated microscopic platform
(Fig EV3B) showed a specific increase in each marker in stimulated
versus unstimulated cells. The absolute number of cells positive for
MCM2 was fivefold to 10-fold higher than cells positive for the S-
G2-M marker Geminin (Fig 1H). Together with observed low levels
of EdU incorporation over a 50-h period, these data suggest that
stimulated MDM re-entered the cell cycle but the majority did not
progress to S, G2/M phase (Figs 1H and EV3C). We confirmed
further that stimulated MDM did not divide using classical propid-
ium iodide (PI) and CFSE staining (Figs 1I and J, and EV3D). These
data suggest that MDM are in a G0/quiescent/terminally differenti-
ated state and that they are able to modulate expression of cell
cycle-associated proteins, without measurable cell division or DNA
synthesis. These early changes are consistent with transition to a
G1-like phase and are associated with increased permissivity to
HIV-1 infection in cultured MDM.
Transition to a G1-like state is sufficient to regulate SAMHD1
antiviral activity in terminally differentiated macrophages
Given the known association between SAMHD1, a well-described
HIV-1 restriction factor in myeloid cells and the cell cycle (Cribier
et al, 2013; White et al, 2013; Pauls et al, 2014; Yan et al, 2015), we
hypothesised that SAMHD1 antiviral activity might be regulated
spontaneously in human MDM. To test this, we examined CDK1/2
expression knowing that CDK1/2 phosphorylates SAMHD1 to deacti-
vate its capacity to restrict infection (Cribier et al, 2013; Welbourn
et al, 2013; White et al, 2013). We found raised expression levels of
CDK1 and pSAMHD1-T592 in stimulated MDM, but not CDK2, CDK4
or CDK6 (Fig 2A). dNTP levels were also increased by threefold to
fourfold in stimulated MDM (Fig EV3E), also consistent with the
reported activity of SAMHD1 (Lahouassa et al, 2012). Furthermore,
exogenously induced degradation of SAMHD1 by co-infection with
SIVmac virus-like particles bearing Vpx (VLP-vpx) (Fig 2B), or deple-
tion of SAMHD1 by siRNA transfection (Fig 2C) led to a 10-fold
increase in HIV-1 infectivity specifically in unstimulated MDM, with
no change in infection in the permissive stimulated MDM where
SAMHD1 is phosphorylated and thus already inactive against HIV-1.
To probe the reversibility of regulation of CDK1/2 and SAMHD1
in MDM, we changed serum 3 days before infection from unstimu-
lating HS to stimulating FCS, and vice versa (Fig 2D and E). Non-
stimulating conditions from day 3 onwards [unstim (day 3), Fig 2D
and E] reduced MCM2 and CDK1 expressions (indicative of cells
returning to a quiescent state), with decreased SAMHD1 phosphory-
lation and HIV-1 infection. Conversely, stimulating conditions from
day 3 [stim (day 3), Fig 2D and E] or from day 7 (Fig EV3F)
augmented HIV-1 infection and was associated with increased
MCM2/CDK1 expression (indicative of cells re-entering the G1-like
state) and SAMHD1 phosphorylation. No significant changes were
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observed for CDK2 expression or phosphorylation (Fig 2E). These
data suggest that this process is reversible in terminally differenti-
ated macrophages.
To further explore the regulation of SAMHD1 in MDM, we
mapped the signalling pathway responsible for SAMHD1 phosphory-
lation by using well-characterised specific inhibitors of kinases
A
E F G
H I J
B C D
Figure 1. Transitioning from G0- to a G1-like phase in terminally differentiated monocyte-derived macrophages (MDM).
A MDM were differentiated and cultured in RPMI complemented with MCSF and 10% human serum (unstim) or with MCSF and 10% foetal calf serum (stim). MDM
were infected with VSV-G-pseudotyped HIV-1 expressing GFP, and the percentage of infected cells was quantified 48 h post-infection by FACS (n = 3, mean  s.e.m.;
**P-value ≤ 0.01, unpaired t-test).
B MDM were infected with HIV-1 BaL and DNA isolated 18 h post-infection for qPCR of late viral RT products (n = 3, mean  s.e.m.; *P-value ≤ 0.05, unpaired t-test).
C Spreading infection in MDM. Cells were infected with HIV-1 BaL, stained for intracellular p24 and quantified by FACS.
D Principal component analysis of expression data for macrophage-associated transcripts to compare relative clustering of stimulated and unstimulated MDM and a
range of primary cells/cell lines.
E Diagram of cellular and molecular functions associated with genes that show significant (log2(P-value) > 2) transcriptional upregulation in stimulated MDM
compared to unstimulated MDM.
F Cell cycle-associated transcripts in stimulated and unstimulated MDM.
G Immunoblot of cell cycle-associated proteins expressed in MDM. Star indicates non-specific band. This Western blot quantification is from Donor 1 in Fig 2A. The
same blots were used in Fig 2A to allow comparison of different cell cycle-associated proteins, as well as SAMHD1.
H Uninfected MDM or MDM exposed for 48 h to VSV-G HIV-1 GFP (HIV-1 exposed) were stained for cell cycle-associated proteins MCM2, Geminin and EdU
incorporation (EdU added to MDM 50 h prior to analysis). On average, 104 cells in each experiment were recorded and analysed using Hermes WiScan cell-imaging
system and ImageJ. Diagram of the cell cycle pathway with associated markers is also shown.
I Cell cycle analysis by quantitation of DNA content by flow cytometry. Cycling THP-1 cells and both unstimulated and stimulated MDM were labelled by propidium
iodide (PI) and analysed by FACS.
J CFSE loaded MDM were cultured for 4 days to determine cell division/proliferation by FACS.
Source data are available online for this figure.
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Figure 2. Bidirectional transitions shape SAMHD1-mediated restriction of HIV-1.
A MDM from three donors (D1, D2, D3) were used for immunoblotting to detect SAMHD1 and CDK proteins. The blot for D1 is the same as that in Fig 1G in order to
facilitate comparison of different cell cycle-associated proteins and SAMHD1.
B MDM were co-infected with VSV-G HIV-1 GFP and SIVmac virus-like particles containing vpx (VLP-vpx). Cells from a representative donor were used for
immunoblotting. The percentage of infected cells was quantified by FACS 48 h post-infection (n = 2, mean  s.e.m.; **P-value ≤ 0.01; (ns) non-significant,
unpaired t-test).
C MDM were transfected with control or pool of SAMHD1 siRNAs and infected 3 days later with VSV-G-pseudotyped HIV-1 GFP. Cells from a representative donor
were used for immunoblotting. The percentage of infected cells was quantified by FACS 48 h post-infection (n = 2, mean  s.e.m.; **P-value ≤ 0.01; (ns) non-
significant, unpaired t-test).
D Experimental approach used to model MDM bidirectional G0–G1-like transitions. MDM were as follows: (unstim) cultured in HS or (stim) cultured in FCS as
described in Materials and Methods; [stim (day 3)] grown in HS conditions for 3 days and changed to stimulating FCS conditions for 3 days; [unstim (3 days)]
grown in stimulating FCS condition for the 3 days and changed to non-stimulating HS for the remaining 3 days.
E Single round of infection of MDM with full-length HIV-1 BaL. Cells were used for immunoblotting to detect CDKs, SAMHD1 and MCM2 proteins. Graph is a
representative example of n ≥ 3, mean  s.e.m.
F Proposed signalling pathway leading to SAMHD1 phosphorylation in stimulated MDM.
G, H Unstimulated (G) and stimulated (H) MDM were treated with inhibitors of RAF (2 lM), B-RAF (3 lM), MEK1/2 (AS-703026, 1 lM), JAK 1–3 (1 lM), GSK3 (2 lM), PIM
1–3 (3 lM) and CDK4/6 (1 lM) for 18 h before infection and infected with VSV-G HIV-1 GFP. The percentage of infected cells was quantified by FACS 48 h post-
infection. Graphs are representative example of n ≥ 3, mean  s.e.m., *P-value ≤ 0.05; **P-value ≤ 0.01; calculated from triplicates, unpaired t-test).
I MDM were treated with a MEK/ERK inhibitor (U0126, 10 lM) for 18 h before infection and where indicated VLP-vpx was added at the time of infection.
Percentage of infected cells were detected by FACS 48 h post-infection. Cells were used for immunoblotting to detect CDKs, SAMHD1 and MCM2 proteins (n = 3,
mean  s.e.m.; (ns) non-significant; ***P-value ≤ 0.001, unpaired t-test).
Source data are available online for this figure.
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(Fig 2F–I). We identified the involvement of the Raf/MEK/ERK
kinase cascade in the regulation of HIV restriction (Figs 2F–I and
EV3G). Of note, the B-Raf inhibitor PLX4032 (active only against the
V600E B-Raf mutant observed in cancer cells) was used as a nega-
tive control to demonstrate specificity of Raf inhibition (Fig 2G and
H). To pharmacologically block the putative signal activated by
FCS, we also used a highly specific inhibitor of MEK/ERK, U0126,
reasoning that this would lead to suppression of HIV-1 infection in a
SAMHD1-dependent manner (Fig 2F). Indeed, MEK/ERK inhibition
substantially inhibited HIV-1 infection of MDM, and loss of HIV-1
permissivity correlated with SAMHD1 dephosphorylation, CDK1
and MCM2 downregulation (Fig 2I). Critically, SAMHD1 depletion
by VLP-vpx (Fig 2I) completely rescued HIV-1 infection from the
inhibitory effect of U0126. This was further confirmed by inhibiting
the signalling pathway downstream from MEK/ERK using a specific
inhibitor of CDK4/6 (Fig EV3G). These data illustrate, for the first
time, that the Raf/MEK/ERK signalling pathway regulates SAMHD1
antiviral activity in terminally differentiated macrophages.
G1-like phase macrophages are preferential targets for HIV at
the single-cell level
We next employed a high-throughput single-cell co-localisation
analysis, aiming to measure the association between SAMHD1,
markers of cell cycle progression and HIV-1 infection at the single-
cell level (Fig 3). We infected MDM with VSV-G-pseudotyped
HIV-1 and 48 h post-infection stained the cells for MCM2 or for
EdU incorporation (added at the time of infection) to monitor
active DNA synthesis and analysed cells by using an automated
microscopic system (Fig 3A–E). As expected, we found that MCM2
expression correlated with HIV infection under both stimulatory
and non-stimulatory conditions (Fig 3A–C and G–J). This analysis
illustrated that macrophages in a G1-like state, measured by
MCM2 expression, are preferential targets for HIV at the single-cell
level. Stimulation by FCS simply increased the number of MCM2-
positive cells and therefore increased the number of permissive
target cells for HIV-1 infection (Fig 3B, C, E, G, and H). This
explains the increased permissivity of stimulated MDM cultures in
Fig 1A. Importantly, even though stimulatory conditions also
increased the number of cells positive for EdU incorporation
(Fig EV4A), the population of cells actively synthesising DNA was
a minority (< 7%) and this increase was not statistically signifi-
cant. As shown earlier, MDM very rarely divide, even under stim-
ulatory conditions (Figs 1I and J, and EV3D). As HIV infection did
not co-localise with EdU incorporation in single-cell analyses, we
conclude that entry into S phase and DNA synthesis is not
required for enhanced HIV-1 infection (Figs 3C and J, and EV4B),
consistent with a G1-like permissivity window.
Critically, degradation of SAMHD1, through co-infection with
SIVmac VLP-vpx, or SAMHD1 depletion using RNAi, completely
abrogated the association between infection of MDM and MCM2
expression (Figs 3D, E and G–J, and EV4C). Indeed, log odds ratios
comparing frequencies of HIV-1 infection in MCM2-positive and
MCM2-negative cells were high, indicating highly specific infection
of MCM2-positive cells, but not MCM2-negative cells. These log
odds ratios were significantly reduced after SAMHD1 depletion indi-
cating that SAMHD1 was responsible for the poor permissivity of
the MCM2-negative cells (Fig 3J). There was no such evidence for
preferential permissivity of Edu-positive cells (Fig 3J). Importantly,
Semliki Forest virus (SFV), an alpha virus with an RNA genome
which replication is dNTP-independent, did not preferentially infect
MDM expressing MCM2 (Figs 3F and J, and EV4D and E). As
predicted, infection of MDM by lentiviruses naturally encoding Vpx
genes (HIV-2, SIVsmE543) also showed significant reduction in log
odds ratios (Fig 3J).
Tissue-resident macrophages commonly reside in a G1-like phase
and are preferential HIV-1 targets
Human MDM are a widely used model for primary macrophages,
but their generation relies on in vitro differentiation from mono-
cytes. We therefore investigated whether tissue-resident macro-
phages could be observed in the G1-like state we describe and
whether this was associated with increased HIV-1 permissivity.
SAMHD1 is conserved in mice and has anti-HIV-1 activity (Behrendt
et al, 2013; Zhang et al, 2014) that, like human SAMHD1, is regu-
lated by phosphorylation (Wittmann et al, 2015). We first isolated
mouse microglia (tissue-resident, yolk sac-derived macrophages of
the brain) and observed between 5 and 20% of these cells express-
ing MCM2 immediately following isolation (Fig EV5). However,
MCM2 staining in microglia appeared to diminish rapidly following
isolation from brain tissue, precluding analysis of the correlation
between MCM2 and HIV-1 infection. We therefore isolated tissue-
resident peritoneal macrophages (of bone marrow origin) (Fig 4)
from both wild-type (WT) and SAMHD1 knock-out (KO) mice
(Rehwinkel et al, 2013). We infected these cells with VSV-G-pseudo-
typed HIV-1 and at 48 h post-infection inspected the cells for speci-
fic macrophage markers F4/80 and CD11b (Fig 4A and B), as well
as expression of MCM2 and EdU incorporation (Fig 4C–I). We
observed that 20% of macrophages from both SAMHD1 WT and KO
mice were positive for MCM2 (Fig 4C and H), but ≤ 1% of cells
incorporated EdU. As before, this suggested a G1-like state that does
not progress into S phase similar to the situation in human MDM
(Fig 4D and I). Critically, and as before, we observed preferential
infection of MCM2-positive cells from WT but not SAMHD1 negative
cells (Fig 4E–G, J and K). There was no correlation between infec-
tion and EdU in macrophages from either WT or KO mice (Fig 4K).
HDAC inhibitors induce a SAMHD1-dependent block to HIV-1 in
human MDM
Histone deacetylase inhibitors (HDACi) can reactivate latent HIV in
a variety of experimental systems (Wightman et al, 2012). HDACi
also induce cell cycle arrest and induce a differentiated phenotype
and/or apoptosis in most carcinoma cell lines (Marks et al, 2000;
Komatsu et al, 2006; West & Johnstone, 2014), but the effect of
these drugs on HIV infection in primary human macrophages is not
known. To test this, we treated MDM with increasing concentrations
of HDACi SAHA (vorinostat) or panobinostat, infected the cells with
VSV-G-pseudotyped HIV-1 and measured the percentage of infected
cells 48 h later. HDACi substantially inhibited HIV-1 infection of
both stimulated and unstimulated MDM (Figs 5A and EV6A) with
no observed cytotoxicity (Fig 5B). For all further experiments, we
used only stimulated MDM (Fig 5B–F), where the majority of cells
are in a G1-like phase and expressing MCM2 and inactive phospho-
rylated SAMHD1. Here, the loss of HIV-1 permissivity following
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HDACi treatment correlated with loss of MCM2 (Fig 5C and D),
CDK1 and SAMHD1 dephosphorylation, suggesting transition of
MDM from G1-phase to a non-permissive, inactive state (Fig 5D).
HDACi treatment of MDM was also associated with increased
expression of cell cycle regulators p27 and p53 (Figs 5D and EV6B)
(Sherr & Roberts, 1999; Wang et al, 2015). SAMHD1 depletion using
A
B
C
G H I J
D
E
F
Figure 3. HIV-1 tropism for G1-like MDM at the cellular level.
A–C MDM were infected with VSV-G-pseudotyped HIV-1 GFP, stained and recorded and analysed for infection, MCM2 expression and co-localisation between infection
and MCM2 protein and EdU incorporation 48 h post-infection using Hermes WiScan cell-imaging system. Random microscopic fields and plot profiles show an
example of immunofluorescence intensity along infected cells. Scale bars: 20 lm.
D, E MDM were infected with VSV-G-pseudotyped HIV-1 GFP in the presence of SIVmac virus-like particles containing vpx (VLP-vpx), stained and recorded 48 h post-
infection using Hermes WiScan cell-imaging system. Random microscopic fields and plot profile show an example of immunofluorescence intensity along infected
cells. Scale bars: 20 lm.
F MDM were infected with Semliki Forest virus (SFV). Random microscopic fields and plot profile show an example of immunofluorescence intensity along infected
cells. Scale bar: 20 lm.
G–I MDM were infected with VSV-G-pseudotyped HIV-1 GFP in the presence or absence of VLP-vpx, stained and recorded 48 h post-infection. On average, 104 cells in
each experiment were recorded and analysed for infection (G), MCM2 expression (H) and co-localisation between infection and MCM2 protein (I) using Hermes
WiScan cell-imaging system and ImageJ (n = 3, mean  s.e.m.; (ns) non-significant; **P-value ≤ 0.01, ***P-value ≤ 0.001, unpaired t-test).
J Log odds ratios calculated from quantifications of stimulated MDM show association of infection with MCM2/EdU (1, high association; 0, no association) (n ≥ 3,
mean  s.e.m.). Immunoblot shows expressions levels of SAMHD1 in these experiments. EdU was added to cells at the time of infection.
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siRNA (Fig 5E and F) or by VLP-vpx (Fig EV6C–F) completely
rescued HIV-1 infection from the inhibitory effect of HDACi. These
data indicate that HDACi possess antiretroviral activity that is
SAMHD1-dependent in macrophages.
Discussion
HIV infects terminally differentiated tissue macrophages within the
gut, lung, lymph nodes and central nervous system (CNS)
(Gonzalez-Scarano & Martin-Garcia, 2005; Yukl et al, 2014; Cribbs
et al, 2015). Macrophages represent the dominant cellular target in
the CNS, and compartmentalised viral populations have been docu-
mented in CSF, consistent with T-cell-independent replication in this
“sanctuary site” (Schnell et al, 2011). As HIV-infected macrophages
are able to release virus over extended periods, they are not only a
potential source of drug-resistant virus, but also a likely barrier to
achieving remission/cure (Watters et al, 2013).
Here, we propose that SAMHD1 is the dominant host factor
controlling post-entry permissivity to infection of non-dividing MDM.
We demonstrate that the SAMHD1 phosphorylation status at T592
controlling antiviral activity is naturally dynamic in primary human
MDM, providing a window of opportunity for HIV-1 infection without
a requirement for an anti-SAMHD1 countermeasure. Intriguingly, the
dynamic phosphorylation of SAMHD1 by CDK1 is associated with
expression of proteins typically associated with cell cycle control.
These include cyclins D1 and D3, cyclins A and E, E2F6, MCM2 and
Geminin. Therefore, despite the fact that that the vast majority MDM
in our experiments do not actually synthesise DNA (lack of EdU
incorporation) or divide (by PI and CFSE assays), we find that MDM
can be stimulated to exit G0 phase and enter a G1-like state. This
transition with associated CDK1 upregulation and T592 phosphoryla-
tion of SAMHD1 renders macrophages permissive to HIV-1.
It is not clear why macrophages should transition between a clas-
sical G0 state and a G1-like state. One possibility is that nucleotide
accumulation is required for repair of damaged DNA, as has been
observed in terminally differentiated post-mitotic neurons (Kruman
et al, 2004).
Our finding that microglia and peritoneal macrophages reside in
the G1-like state may explain how macrophages can sustain HIV-1
A B C
E F
D
G H I J K
Figure 4. HIV-1 tropism for murine tissue-resident macrophages at the cellular level.
A–D Peritoneal macrophages from 6- to 10-week-old C57BL/6 mice were stained for the macrophage markers (A) F4/80, (B) CD11b, (C) MCM2 or (D) active DNA
synthesis (EdU) 2 h after isolation. Scale bars: 20 lm.
E–K Peritoneal macrophages were isolated from 6- to 10-week-old WT or SAMHD1/ (KO) mice. Cells were infected with VSV-G-pseudotyped HIV-1 GFP for 48 h and
analysed for (G) infection, (H) MCM2 expression, (I) EdU incorporation (EdU was added at the time of infection), and co-localisation between infection and (J)
MCM2 protein or (K) active DNA synthesis (by EdU incorporation). (E, F) Random microscopic fields and plot profiles show an example of immunofluorescence
intensity along infected cells. Scale bars: 10 lm. On average, 104 cells in each experiment were recorded and analysed using Hermes WiScan cell-imaging system
and ImageJ (n ≥ 2, mean  s.e.m.; (ns) non-significant; **P-value ≤ 0.01, unpaired t-test).
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infection in the absence of T cells within a humanised mouse model
(Honeycutt et al, 2016). Importantly, we could recapitulate the G1-
like HIV-1 permissivity window in freshly isolated peritoneal macro-
phages from mice. This demonstrates that the dynamic SAMHD1
regulation is conserved in mice and that in vivo macrophages are
likely to experience the transitions we describe. We found that cells
taken directly from mouse brain, in contrast to peritoneum,
frequently reverted from G1-like phase to the quiescent state. This
suggests either that microglia are intrinsically programmed to more
readily revert back to a quiescent state than peritoneal macrophages
or that maintenance of the G1-like state in microglia requires speci-
fic local tissue factors.
The brain is sometimes referred to as a “sanctuary” site where
isolated primate lentiviral replication occurs in myeloid cells, includ-
ing perivascular macrophages and microglia (Williams et al, 2001;
Schnell et al, 2009, 2010; Micci et al, 2014). Our biological insights
into dynamic changes essential for HIV-1 infection in macrophages
may be particularly relevant for HIV neuropathology given observa-
tions that symptomatic patients on long-term fully suppressive
combination antiretroviral therapy (ART) can have isolated viral
replication in the CNS (Schnell et al, 2009, 2010; Canestri et al,
2010; Hammond et al, 2016). We speculate that the brain micro-
environment could modulate G0- to G1-like transitions in brain
myeloid cells and thereby impact HIV replication in the CNS and
HIV persistence in this compartment.
In the light of the above, induction of a state of cellular resistance
to HIV infection by host-directed therapy in addition to ART is
highly desirable as we search to achieve sustained HIV remission.
This may be particularly important if combination ART cannot
prevent ongoing low-level replication and evolution (Lorenzo-
Redondo et al, 2016). Here, we reveal a hitherto unrecognised
SAMHD1-dependent antiretroviral activity of HDACi in macro-
phages. In addition to their known effects on gene transcription
(West & Johnstone, 2014) and HIV reactivation from latency
through histone modification, HDACi activate SAMHD1 antiviral
activity via p53-induced cell cycle exit, CDK1 depletion and loss of
SAMHD1 phosphorylation. The ability to reactivate latent virus and
to prevent infection of new target cells is a major advantage of these
A D
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Figure 5. HDAC inhibitors induce a SAMHD1-dependent block to HIV-1 infection in macrophages.
A MDM were treated with increasing concentrations of the HDAC inhibitor SAHA 18 h before infection with VSV-G-pseudotyped HIV-1 GFP. The percentage of
infected cells was measured using FACS 48 h post-infection. Graph is representative example of n ≥ 3, mean  s.e.m.
B Stimulated MDM were treated with 1 lM SAHA and 48 h later stained for viability using a cell viability assay (LIVE/DEAD) (n ≥ 2, mean  s.e.m.; (ns) non-
significant, unpaired t-test). H2O2 was used as a positive control to induce cell death.
C Stimulated MDM were treated with 1 lM SAHA, and MDM were recorded and analysed for MCM2 protein expression using Hermes WiScan (n = 3, mean  s.e.m.;
**P-value ≤ 0.01, unpaired t-test).
D Stimulated MDM were treated with 1 lM SAHA, MDM were lysed, and immunoblotting was performed to detect cell cycle-associated proteins.
E, F MDM were transfected with control or pool of SAMHD1 siRNAs and infected 3 days later with VSV-G-pseudotyped HIV-1 GFP. Cells from a representative donor
were (E) lysed and used for immunoblotting or (F) inspected for infection. Scale bars: 20 lm. On average, 104 cells in each experiment were recorded and analysed
using Hermes WiScan cell-imaging system and ImageJ (n ≥ 2, mean  s.e.m.).
Source data are available online for this figure.
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agents as they enter clinical trials as candidates for achieving func-
tional HIV cure.
We mapped activation of the Raf/MEK/ERK signalling cascade
after addition of FCS. However, we have not identified the factor(s)
leading to transition to the G1-like phase and differential effects of
FCS and HS on SAMHD1 activity in MDM. FCS and HS differ in a
number of ways, including concentration of growth factors,
hormones and endotoxin. Charcoal stripping but not boiling of FCS
abrogated the enhanced permissivity arising from FCS culture,
consistent with a hormone or fatty acid being the putative active
agent. Furthermore, it is currently unclear whether the differential
effect on SAMHD1 is due to differences between foetal and adult
sera or differences between human and bovine sera. Indeed, we
could not reproduce the effect of FCS using human cord blood-
derived serum (data not shown).
Recently, Badia et al reported that MDM cultured in the presence
of GM-CSF induced the expression of cyclin D2 with downstream
changes in SAMHD1 phosphorylation and increased susceptibility to
HIV-1 infection (Badia et al, 2016). In particular, they were unable
to detect cyclin D2 expression by Western blot in either HS or FCS
cultured M-CSF stimulated macrophages, despite differences in
susceptibility to HIV-1 and SAMHD1 phosphorylation. Concor-
dantly, we report undetectable cyclin D2 under both culture condi-
tions, consistent with a cyclin D2-independent mechanism activated
by FCS that is driven by the Raf/MEK/ERK signalling pathway and
CDK1 regulation.
In summary, we have answered the question of how HIV-1
infects SAMHD1 expressing macrophages without encoding a Vpx-
like SAMHD1 antagonist. We have found that MDM and tissue-
resident macrophages exist in their typical terminally differentiated/
quiescent/G0 state, but also in a G1-like state. Those in G0 can be
stimulated into re-entering the G1-phase of the cell cycle, without
evidence for cell division, accompanied by deactivation of SAMHD1
by phosphorylation. This allows efficient HIV-1 replication without
the need to degrade SAMHD1. SAMHD1 shutdown provides a
window of opportunity for HIV-1 infection, and we believe that this
is how HIV-1 can infect macrophages in vivo. The translational
potential of this new knowledge is exemplified by our demon-
stration that HDAC inhibitors can block HIV infection at the pre-
integration stage through activation of SAMHD1, thereby protecting
these critical immune cells.
Materials and Methods
Reagents, inhibitors, antibodies, plasmids
Tissue culture media and supplements were obtained from Invitro-
gen (Paisley, UK), and tissue culture plastic was purchased from
TPP (Trasadingen, Switzerland). FCS (FBS) was purchased from
Biosera (Boussens, France) and Sigma (Sigma, St. Louis, MO, USA).
Charcoal-stripped FCS was purchased from Sigma. Human serum
from human male AB plasma was of USA origin and sterile-filtered
(Sigma). All chemicals were purchased from Sigma unless indicated
otherwise. Kinase inhibitors used: CDK4/6 inhibitor (PD 0332991,
Palbociclib) from Sigma; MEK/ERK inhibitor U0126 from Calbio-
chem (San Diego, USA); JAK 1–3 (ruxolitinib), PIM 1–3 (AZD1897),
GSK3 (CT99021), and MEK1/2 (AS-703026), RAF (TAK-632),
B-RAF (PXL4032) from Selleckchem (Houston, TX, USA), SAHA
(vorinostat) from Sigma and panobinostat from Cayman Chemicals
(Ann Arbor, MI, USA). Antibodies used were as follows: anti-cdc2
(Cell Signaling Technology, Beverly, MA, USA); anti-CDK2 (H-298,
Santa Cruz Biotechnology); anti-pCDK2(Thr160) (Bioss Inc., MA,
USA); anti-CDK4 (DCS156, Cell Signaling Technology); anti-CDK6
(B-10, Santa Cruz Biotechnology); anti-SAMHD1 (ab67820, Abcam,
UK), beta-actin (ab6276, abcam, UK); mouse anti-MCM2 (BM-28,
BD Biosciences, UK); and rabbit anti-MCM2 (SP85) from Sigma;
pSAMHD1 (a kind gift from M. Benkirane) and ProSci (Poway, CA,
USA); anti-Geminin (NCL-L-Geminin, Leica); anti-mouse F4/80 and
CD11b (kind gift from S. Yona, UCL); anti-human CD68, CD14,
CD163, CD80, CD86, CD40 (kind gift from M. Noursadeghi).
All infectious molecular clones were obtained from the NIH
AIDS Research and Reference Reagent Program (Germantown, MD,
USA).
Cell lines and viruses
TZM-bl HeLa and 293T cells were cultured in DMEM complete
(DMEM supplemented with 100 U/ml penicillin, 0.1 mg/ml strepto-
mycin and 10% FCS). HIV-1 full-length virus stocks were generated
by DNA plasmid transfection of 293T using Fugene HD (Promega
UK Ltd, UK) according to the manufacture’s protocol. Viral super-
natants were harvest 48 h post-transfection and filtered through
0.45-lm pore-size filters and stored at 80°C. Clarified viral super-
natants were analysed by p24 ELISA (AIDS and Cancer Virus
Program NCI-Frederick, MD, USA) for HIV-1 p24 antigen quan-
tification. SIVmac virus-like particles containing Vpx were prepared
as previously described (Goujon et al, 2008). VSV-G HIV-1 GFP
virus was produced by transfection of 293T with GFP-encoding
genome CSGW, packaging plasmid p8.91 and pMDG as previously
described (Besnier et al, 2002). SFV was kind gift from M. Mazzon
(UCL). VSV-G HIV-2 GFP virus was produced as previously
described (Ylinen et al, 2005), and VSV-G SIVsmE543 GFP virus
was kind gift from G. Towers (UCL).
Monocyte isolation and differentiation
PBMC were prepared from HIV-seronegative donors (after informed
consent was obtained), by density-gradient centrifugation (Lympho-
prep, Axis-Shield, UK). MDM were prepared by adherence with
washing of non-adherent cells after 2 h, with subsequent mainte-
nance of adherent cells in RPMI 1640 medium supplemented with
10% human serum or 10% foetal calf serum and MCSF (10 ng/ml)
for 3 days and then differentiated for a further 4 days in RPMI 1640
medium supplemented with 10% human/foetal calf sera without M-
CSF. Human AB serum (Sigma) was used to prepare unstimulated
cells or FCS (Biosera or Sigma) to prepare stimulated cells.
Infection of primary cells using full-length and VSV-G-
pseudotyped HIV-1 viruses
MDM were infected with 50 ng of p24 of each virus for 4 h. Cells
were washed in PBS, and new complete medium was added. MDM
were fixed in ice-cold acetone–methanol (1:1 [vol/vol]) 2 days post-
infection, and infected cells identified by staining for p24 protein
using a 1:1 mixture of the anti-p24 monoclonal antibodies EVA365
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and EVA366 (NIBSC, Center for AIDS Reagents, UK) and a
secondary goat anti-mouse beta-galactosidase-conjugated antibody
(SouthernBiotech, AL, USA) and visualised by X-Gal (5-bromo-4-
chloro-3-indolyl-b-d-galactopyranoside) staining (Promega). Virus-
infected cells were detected by light microscopy. Alternatively,
MDM were fixed in 3% PFA, permeabilised by saponin and stained
for intracellular p24 using anti-p24 FITC-conjugated antibody (Santa
Cruz Biotechnology, USA). The percentage of infected cells was
monitored by flow cytometry using BD FACSCalibur (BD Bio-
sciences, UK) and analysed by CellQuest (BD Biosciences) and
FlowJo software (Tree Star, OR, USA). GFP containing VSV-G-
pseudotyped HIV-1 was added to cells (MDM and tissue-resident
macrophages from mice), and after 4-h incubation, removed and
cells were washed in culture medium. The percentage of infected
cells was determined 48 h post-infection by flow cytometry using
BD FACSCalibur (BD Biosciences, UK) and analysed by CellQuest
(BD Biosciences) and FlowJo software (Tree Star, OR, USA) or by
Hermes WiScan-automated cell-imaging system (IDEA Bio-Medical
Ltd. Rehovot, Israel) and analysed using MetaMorph and ImageJ
software.
Quantitative PCR for total HIV DNA quantitation
Total HIV DNA was detected as previously described (Mlcochova
et al, 2014).
Measurement of HIV-1 entry (BlaM-Vpr assay)
HIV-1 entry was measured as previously described (Mlcochova
et al, 2014).
TZM-bl assay
Supernatants from BaL-infected MDM were harvested, filtered using
0.45-lm pore-sized filters and used to infect TZM-bl cells. Luciferase
activity of the TZM-bl cells was measured 24 h post-infection using
the Steady Glo Firefly Luciferase assay (Promega) and GloMax96
Luminometer (Promega).
SDS–PAGE and immunoblots
Cells were lysed in reducing Laemmli SDS sample buffer containing
PhosSTOP (Phosphatase Inhibitor Cocktail Tablets, Roche, Switzer-
land) at 96°C for 10 min and the proteins separated on NuPAGE
Novex 4–12% Bis–Tris Gels. Subsequently, the proteins were
transferred onto PVDF membranes (Millipore, Billerica, MA, USA),
the membranes were quenched, and proteins detected using specific
antibodies. Labelled protein bands were detected using Amersham
ECL Prime Western Blotting Detection Reagent (GE Healthcare,
USA) and Amersham Hyperfilm or AlphaInnotech CCD camera.
Protein band intensities were recorded and quantified using
AlphaInnotech CCD camera and AlphaView software (Protein-
Simple, San Jose, CA, USA).
RNA microarrays
Total RNA was purified from cell lysates collected in RLT buffer
(Qiagen) using the RNeasy Mini kit (Qiagen). Samples were
processed for Agilent microarrays, and data were normalised as
previously described (Chain et al, 2010). Microarray data are
available in the ArrayExpress database under accession number
E-MTAB-2985 for stimulated MDM (differentiated in FCS) and
E-TABM-1206 for all other cell types presented in this study.
The macrophage-associated gene expression module was used as
previously described (Tomlinson et al, 2012), and genes encod-
ing nuclear proteins were derived from the Gene Ontology
consortium database (AmiGO v1.8, http://amigo1.geneontology.
org/cgi-bin/amigo/go.cgi), under accession number GO:0005634,
filtered for cellular compartment and for Homo sapiens, to give
6,164 unique genes with gene symbol annotations. Ingenuity
pathway analysis (Ingenuity Systems, www.ingenuity.com) was
used to identify significantly enriched pathways among 170
genes with > twofold expression in stimulated and unstimulated
MDM.
Cell proliferation assay, propidium iodine and CFSE labelling
Cell proliferation was measured by tracking new DNA synthesis
using Click-iT EdU Alexa Fluor 488 Kit (Invitrogen). EdU was
added to culture medium at 5 lM for 2 h or 2–4 days depending on
experiment. Labelled cells were detected using the Hermes WiScan-
automated cell-imaging system (IDEA Bio-Medical Ltd. Rehovot,
Israel) and analysed using MetaMorph and ImageJ software. For
propidium iodine (PI) staining: cells were fixed in 70% ethanol,
treated with RNAse and stained with PI (0.1 mg/ml), monitored by
flow cytometry using BD FACSCalibur and analysed by CellQuest
and FlowJo software. 5 lM CFSE was added to MDM according to
CellTraceTM CFSE Cell Proliferation Kit manufacturer protocol (Ther-
moFisher, Waltham, MA, USA), and cells were left in culture to
show potential cell division for an additional 6 days. CFSE labelling
was conducted according to CellTraceTM CFSE Cell Proliferation Kit
manufacturer protocol. Cells were monitored by flow cytometry
using BD FACSCalibur and analysed by CellQuest and FlowJo
software.
Immunofluorescence
MDMs were fixed in 3% PFA, quenched with 50 mM NH4Cl
and permeabilised with 0.1% Triton X-100 in PBS or 90%
methanol. After blocking in PBS/1% FCS, MDMs were labelled
for 1 h with primary antibodies diluted in PBS/1% FCS, washed
and labelled again with Alexa Fluor secondary antibodies for
1 h. Cells were washed in PBS/1% FCS and stained with DAPI
in PBS for 20 min. Labelled cells were detected using Hermes
WiScan-automated cell-imaging system (IDEA Bio-Medical Ltd.
Rehovot, Israel) and analysed using MetaMorph and ImageJ
software.
SAMHD1 knock-down by siRNA
1 × 105 MDM differentiated in MCSF for 4 days were transfected
with 20 pmol of siRNA (L-013950-01, Dharmacon) using Lipofec-
tamine RNAiMAX Transfection Reagent (Invitrogen). Transfection
medium was replaced after 18 h with RPMI 1640 medium supple-
mented with 10% human AB serum or 10% FCS and cells cultured
for additional 3 days before infection.
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Tissue-resident brain macrophages
All work conformed to United Kingdom Home Office legislation (Sci-
entific Procedures Act 1986) (https://www.gov.uk/government/pub
lications/consolidated-version-of-aspa-1986). Adult CD1 mice aged
8–12 weeks were anaesthetised using 20% Pentoject and perfused
with ice-cold PBS. Microglia were isolated as previously described
(Denk et al, 2016). Briefly, brains were dissected and homogenised
using dounce tissue homogeniser in 0.2% BSA supplemented
Hank’s balanced salt solution (HBSS). Microglia were isolated using
a Percoll density gradient (37% versus 70%). Cells were subse-
quently counted using haemocytometer and plated in 96-well plates
at 2.5 × 104–5 × 104 cells/well. Cells were maintained in DMEM/
F12 with 10% FCS at 37°C, 5% CO2 until further use.
Tissue-resident peritoneal macrophages
Six- to ten-week-old C57BL/6 wild-type and knock-out mice were
used in accordance with the UK Home Office Scientific Procedures
Act 1986. Peritoneal cavities were washed with PBS supplemented
with 3 mM EDTA. Following gentle massage, the cavity was opened
by abdominal incision and lavage fluid collected. Fluid was
centrifuged 500 g for 5 min, and cells were re-suspended in
DMEM + 10% FCS and cultured for 2 h before staining or infection.
dNTP measurement
The dNTP levels in the relevant cell types were measured by the
HIV-1 RT-based dNTP assay as previously described (Diamond
et al, 2004).
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